Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DMZG | ISIN: US2244411052 | Ticker-Symbol: P8Q
Frankfurt
21.01.25
08:01 Uhr
61,50 Euro
0,00
0,00 %
1-Jahres-Chart
CRANE NXT CO Chart 1 Jahr
5-Tage-Chart
CRANE NXT CO 5-Tage-Chart
RealtimeGeldBriefZeit
63,5064,0021.01.
63,5064,0021.01.
GlobeNewswire (Europe)
228 Leser
Artikel bewerten:
(1)

Crane NXT, Co. Announces Appointment of Dr. Aleta Richards as President of Crane Currency

Finanznachrichten News

WALTHAM, Mass., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Crane NXT, Co. (NYSE: CXT) ("Crane NXT" or the "Company"), a premier industrial technology company, today announced it has appointed Dr. Aleta Richards as President of its Crane Currency business, effective October 14, 2024. In this role, Dr. Richards will partner with the Crane Currency leadership team to execute the growth strategy, accelerate innovation, and leverage the Crane Business System to drive continuous improvement as a leading integrated supplier of secure, well-designed banknotes, counterfeit resistant security technology and durable banknote paper. Dr. Richards will report directly to Sam Keayes, Senior Vice President, Security and Authentication Technologies, Crane NXT.

Mr. Keayes stated, "We are thrilled to welcome Dr. Richards to Crane Currency. Aleta is a talented leader who will focus on the growth and development of the Crane Currency business and team. Aleta brings more than 30 years of leadership experience, and a track record of growing technology led businesses. I am excited about the future growth and success of Crane Currency and look forward to seeing the business continue to flourish under Aleta's leadership."

Dr. Richards stated, "I am excited to join Crane Currency and contribute to its success in such a dynamic market. I look forward to collaborating with a talented team, leveraging my experience, and adapting to the ever-changing landscape to help drive innovation and growth."

Dr. Richards brings a wealth of experience to Crane Currency. She was most recently Executive Vice President at Covestro, a leading supplier of polyurethane and polycarbonate technologies. There, she led the global specialty films business, based in Germany, that provided high-security technology for passports, medical and other applications. Previously, Dr. Richards led sales and marketing for Covestro's CAS North American business. Earlier in her career, she served as head of Bayer's U.S. Human Resources organization, supporting 14,000 employees.

Dr. Richards has a strong commercial background and extensive experience working with customers around the world. Her sales and marketing expertise has included government and medical sectors. Her passion for innovation and technology, ability to find new markets for established products, international experience, and strong track record of developing high performing teams make her an excellent addition to the Crane Currency team.

Dr. Richards holds a Doctorate in Business Administration from Georgia State University. Additionally, she holds an M.B.A. in Marketing and International Business and a BSc. in Communication and Human Resources from the University of Pittsburgh. She was elected to the Board of Directors for Matthews International in 2023. In 2024, Dr. Richards was recognized by Savoy Magazine as one of the Most Influential Executives in Corporate America and named a finalist for WeQual's EMEA Commercial Award.

About Crane NXT, Co.

Crane NXT is a premier industrial technology company that provides trusted technology solutions to secure, detect, and authenticate what matters most to its customers. Through its two industry-leading business segments, Security & Authentication Technologies and Crane Payment Innovations, Crane NXT provides customers with advanced technologies to secure high-value physical products, sophisticated detection equipment and systems, and proprietary products and services that protect brand identity and digital content. Crane NXT's approximately 4,500 employees help our customers protect their most important assets and ensure secure, seamless transactions around the world every day. For more information, visit?www.cranenxt.com.

Contact:
Investor Relations
ContactUs@cranenxt.com


© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.